Skip to content

National Eye Institute

The nation's leader in vision research.

The mission of the National Eye Institute is to eliminate vision loss and improve quality of life through vision research.

Learn more about NEI

Bespoke Gene Therapy Consortium (BGTC)

NIH has recently launched an Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC). The BGTC seeks tools to streamline the gene therapy development process and nominations for rare diseases for adeno-associated virus vector trials. Deadline: February 18, 2022

Learn more

NEI Research News

Jackie Norrie and Victoria Honnell

Modular super-enhancer controls retinal development

January 11, 2022

Scientists at St. Jude Children’s Research Hospital identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a ‘modular’ super-enhancer.
Group of cells tinted purple in the middle and pink at the edges representing a human induced stem cell colony from a patient with albinism.

NIH researchers develop first stem cell model of albinism to study related eye conditions

January 11, 2022

Researchers at the National Eye Institute (NEI) have developed the first patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism (OCA).
Rod outer segment showing connector

UC Irvine researchers reveal molecular mechanisms of eye disease using cryo-electron tomography

January 4, 2022

Understanding the key structural determinants of a highly specialized membrane in the eye could lead to new treatments.

Funding for Vision Research

NEI funds more than 1,500 research and training grants to vision scientists across the country and around the world.

Learn more about funding opportunities